NASDAQ : IMPL

Impel Pharmaceuticals Inc. — Earnings Estimates

$0.04 USD

-$0.01 (-27.27%)

Volume
720.03K
Average Volume
1.05M
Market Capitalization
$956K
P/E Ratio
-0.01
Dividend Yield
0.00%
Price Target
Year High
$4.20
Year Low
$0.02
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.60

Annual earnings financials

IMPL financial data with annual/quarterly toggle

IMPL GAAP EPS - Annual & Quarterly

IMPL Sales Revenue - Annual & Quarterly

IMPL Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

IMPL Estimated and Actual Revenue by Quarter
IMPL Estimated and Actual EPS by Quarter
IMPL Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2024-09-30 0 - - - - - -
2024-06-30 0 - - - - - -
2024-03-30 0 - - - - - -
2023-12-30 1 - - - - - -
2023-09-30 1 - - - - - -
2023-06-30 2 - - - - - -
IMPL Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2024-09-30 0 36.61M 36.61M 36.61M - - -
2024-06-30 0 31.88M 31.88M 31.88M - - -
2024-03-30 0 37.44M 37.44M 37.44M - - -
2023-12-30 1 -4.99M -4.99M -4.99M - - -
2023-09-30 1 -8.55M -8.55M -8.55M - - -
2023-06-30 2 28.31M 28.31M 28.31M - - -
IMPL Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2024-09-30 0 14.81M 14.81M 14.81M 0 1.54141 1.54141 1.54141
2024-06-30 0 13.17M 13.17M 13.17M 0 1.34259 1.34259 1.34259
2024-03-30 0 11.52M 11.52M 11.52M 0 1.57645 1.57645 1.57645
2023-12-30 1 9.7M 9.7M 9.7M 1 -0.21 -0.21 -0.21
2023-09-30 1 8M 8M 8M 1 -0.36 -0.36 -0.36
2023-06-30 2 6.58M 6.58M 6.58M 1 1.19229 1.19229 1.19229